UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000035937
Receipt No. R000040939
Scientific Title A verification study of effectiveness to skin condition of women by oral consumption of the food which contain black tea fragrance.
Date of disclosure of the study information 2019/02/22
Last modified on 2019/07/03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A verification study of effectiveness to skin condition of women by oral consumption of the food which contain black tea fragrance.
Acronym Study of effectiveness to skin condition of women by consumption of the black tea fragrance containing food.
Scientific Title A verification study of effectiveness to skin condition of women by oral consumption of the food which contain black tea fragrance.
Scientific Title:Acronym Study of effectiveness to skin condition of women by consumption of the black tea fragrance containing food.
Region
Japan

Condition
Condition Not applicable
Classification by specialty
Not applicable
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To verify the influence to skin condition of women by oral consumption of black tea fragrance containing food.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes *Moisture content of Stratum Corneum
*Transepidermal Water Loss(TEWL)
*Viscoelasticity of the skin
*Skin color
*VISIA's indicators(pores, spots, wrinkles, texture, red areas, UV spots, porphyrins, brown spots)
*Blood flow
*Skin temperature
*Brain stress
*Stabilometry
*Questionnaire
*Vascular age
Key secondary outcomes * Incidence of adverse events
* Incidence of side effects

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Single blind -investigator(s) and assessor(s) are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 During in first period, intake one tablet of test food at once, four times a day for three weeks. And during in second period, intake one tablet of control food at once, four times a day for three weeks. No washout period is prepared.
Interventions/Control_2 During in first period, intake one tablet of control food at once, four times a day for three weeks. And during in second period, intake one tablet of test food at once, four times a day for three weeks. No washout period is prepared.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
25 years-old <=
Age-upper limit
39 years-old >=
Gender Female
Key inclusion criteria (1) Females aged 25 to 39 years old.
(2) Subjects who recognize stress and dryness of their skin as subjective symptoms.
(3) Subjects who use more than two kind of cosmetics in order to skin care on a daily basis.
(4) Subjects who show understanding of the clinical study procedures and agreement with participating the study by written informed consent.
Key exclusion criteria (1) Subjects who are currently receiving medication due to treatment of disease.
(2) Subjects who have smoking habit.
(3) Subjects who are treated hormone therapy.
(4) Subjects who have symptom of rhinitis during test period.
(5) Subjects who consume medicines, foods for specified health use, functional foods, supplements and/or health foods which may affect their skin quality more than three times a week.
(6) Subjects who plan to go long travel during test period.
(7) Subjects who can't do UV care when they go out during test period.
(8) Subjects who are cold-sensitive constitution. (including subjects like that who feel cold on their hands and foots even in summer)
(9) Subjects who have symptom of dermatologic disease such as atopic dermatitis.
(10) Subjects who have undergone surgery on investigation objective portion within the past 6 months.
(11) Subjects who are participating the other clinical tests of medicines or foods. Subjects who participated other clinical tests of medicines or foods within a month prior to the current study.
(12) Subjects who themselves and/or their family are working for a company that develops, manufactures or sells health / functional foods and cosmetics.
(13) Subjects who dislike black tea fragrance.
(14) Pregnant or expected pregnant, or lactating women.
(15) Others who have been determined ineligible by investigator.
Target sample size 24

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Yukihiro Yada
Organization University of Tsukuba
School of Integrative
Division name Global Majors
Zip code
Address 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8577 Japan
TEL 029-853-7344
Email yada.yukihiri.gb@u.tsukuba.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Miyuki Fujishiro
Organization COSMOS TECHNICAL CENTER CO.,LTD.
Division name Department of Efficacy and Safety Evaluation
Zip code
Address 3-24-3 Hasune Itabashi-ku, Tokyo 174-0046, Japan
TEL 03-3966-7755
Homepage URL
Email fujishiro@ns-cosmos.co.jp

Sponsor
Institute COSMOS TECHNICAL CENTER CO., LTD.
Institute
Department

Funding Source
Organization Mitsui Norin Co., Ltd.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 02 Month 22 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2019 Year 02 Month 15 Day
Date of IRB
2019 Year 02 Month 15 Day
Anticipated trial start date
2019 Year 02 Month 22 Day
Last follow-up date
2019 Year 04 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2019 Year 02 Month 19 Day
Last modified on
2019 Year 07 Month 03 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040939

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.